StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)

Close on Nov 17, 2026Market cap $3.00BP/E –Yield –

Telix Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Telix Pharmaceuticals's total assets was $1.36B at Jun 30, 2026. For fiscal 2025 it was $1.16B, up 23.8% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.16B+23.8%
FY2024Dec 31, 2024$940.38M+239.2%
FY2023Dec 31, 2023$277.26M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.36B–
Q4 FY2025Dec 31, 2025$1.16B–
Q4 FY2024Dec 31, 2024$940.38M–
Q4 FY2023Dec 31, 2023$277.26M–

More Telix Pharmaceuticals figures

See a number that looks wrong?